Simplex Trading
SGMO

Simplex Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Simplex Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.3K Buy
357,500
+73,200
+26% +$29.1K ﹤0.01% 5241
2025
Q4 		$119K Sell
284,300
-57,700
-17% -$30.6K ﹤0.01% 4803
2025
Q3 		$230K Buy
342,000
+63,200
+23% +$34.1K ﹤0.01% 4772
2025
Q2 		$150K Sell
278,800
-247,500
-47% -$147K ﹤0.01% 4801
2025
Q1 		$345K Sell
526,300
-71,800
-12% -$76K ﹤0.01% 3781
2024
Q4 		$610K Buy
598,100
+370,200
+162% +$677K ﹤0.01% 3325
2024
Q3 		$197K Buy
+227,900
New +$167K ﹤0.01% 4528
2024
Q2 		– Sell
-10,900
Closed -$7K – 9699
2024
Q1 		$7K Buy
10,900
+4,500
+70% +$3.26K ﹤0.01% 7858
2023
Q4 		$3K Buy
+6,400
New +$2.95K ﹤0.01% 8145
2023
Q3 		– Sell
-45,200
Closed -$58K – 9704
2023
Q2 		$58K Buy
45,200
+25,200
+126% +$34.4K ﹤0.01% 5700
2023
Q1 		$35K Sell
20,000
-8,800
-31% -$25.1K ﹤0.01% 6336
2022
Q4 		$90K Sell
28,800
-6,800
-19% -$26.4K ﹤0.01% 5208
2022
Q3 		$174K Buy
35,600
+6,000
+20% +$30.8K ﹤0.01% 4790
2022
Q2 		$122K Buy
29,600
+21,100
+248% +$91.2K ﹤0.01% 5289
2022
Q1 		$49K Sell
8,500
-28,400
-77% -$169K ﹤0.01% 7160
2021
Q4 		$276K Buy
36,900
+3,900
+12% +$33.9K ﹤0.01% 4697
2021
Q3 		$396K Buy
33,000
+800
+2% +$7.91K ﹤0.01% 4460
2021
Q2 		$385K Buy
+32,200
New +$365K ﹤0.01% 4567
2021
Q1 		– Sell
-801
Closed -$1.25M – 9899
2020
Q4 		$1.25M Buy
801
+302
+61% +$3.54K ﹤0.01% 2273
2020
Q3 		$471K Sell
499
-348
-41% -$3.76K ﹤0.01% 3075
2020
Q2 		$758K Sell
847
-12
-1% -$111 ﹤0.01% 2409
2020
Q1 		$547K Sell
859
-72
-8% -$534 ﹤0.01% 2496
2019
Q4 		$779K Buy
931
+137
+17% +$1.26K ﹤0.01% 2317
2019
Q3 		$718K Buy
794
+327
+70% +$3.67K ﹤0.01% 2269
2019
Q2 		$502K Sell
467
-199
-30% -$2.12K ﹤0.01% 2559
2019
Q1 		$635K Sell
666
-65
-9% -$664 ﹤0.01% 2412
2018
Q4 		$839K Sell
731
-840
-53% -$10.4K ﹤0.01% 1775
2018
Q3 		$2.66M Buy
1,571
+1,154
+277% +$17.5K 0.01% 1017
2018
Q2 		$592K Sell
417
-114
-21% -$1.89K ﹤0.01% 2286
2018
Q1 		$421K Buy
531
+421
+383% +$9K 0.02% 801
2017
Q4 		$22K Buy
110
+2
+2% +$30 ﹤0.01% 3218
2017
Q3 		$5K Sell
108
-177
-62% -$1.96K ﹤0.01% 4424
2017
Q2 		$30K Sell
285
-244
-46% -$1.56K ﹤0.01% 2898
2017
Q1 		$32K Buy
529
+358
+209% +$1.44K ﹤0.01% 2785
2016
Q4 		$56K Sell
171
-98
-36% -$357 ﹤0.01% 2041
2016
Q3 		$45K Buy
269
+37
+16% +$188 ﹤0.01% 2199
2016
Q2 		$40K Buy
232
+102
+78% +$650 ﹤0.01% 2265
2016
Q1 		$69K Sell
130
-210
-62% -$1.26K 0.01% 1666
2015
Q4 		$70K Buy
340
+305
+871% +$2.35K 0.01% 1643
2015
Q3 		$37K Buy
+35
New +$289 ﹤0.01% 2237
2015
Q2 		– Sell
-290
Closed -$40K – 5787
2015
Q1 		$40K Buy
290
+63
+28% +$975 ﹤0.01% 1733
2014
Q4 		$12K Buy
+227
New +$2.76K ﹤0.01% 2466

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Simplex Trading's SGMO Position: Q4 2025 in Review

Simplex Trading sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025, closing a stake of 9,609 shares — an estimated $5.09K sold.

Simplex Trading first reported a position in SGMO in Q4 2014 and held it in 36 quarters. The position peaked at $957K in Q1 2018. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

  • Simplex Trading reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 9,609 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $5.09K.
  • Simplex Trading first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 36 quarters.
  • Simplex Trading's SANGAMO THERAPEUTICS INC position peaked at $957K in Q1 2018.
  • 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.